2-chloro-n(6)cyclopentyladenosine has been researched along with Ventricular Fibrillation in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brodmann, M; Lueger, A; Stark, G; Stark, U | 1 |
| Downey, JM; Liu, Y | 1 |
2 other study(ies) available for 2-chloro-n(6)cyclopentyladenosine and Ventricular Fibrillation
| Article | Year |
|---|---|
Antiarrhythmic effects of adenosine on ischemia-induced ventricular fibrillation.
Topics: Adenosine; Animals; Anti-Arrhythmia Agents; Dipyridamole; Female; Guinea Pigs; In Vitro Techniques; Male; Myocardial Ischemia; Purinergic P1 Receptor Agonists; Theophylline; Ventricular Fibrillation | 2001 |
Ischemic preconditioning protects against infarction in rat heart.
Topics: Adaptation, Physiological; Adenosine; Animals; Coronary Disease; Glyburide; Heart; In Vitro Techniques; Male; Myocardial Infarction; Purinergic Antagonists; Rats; Rats, Sprague-Dawley; Tachycardia, Ventricular; Ventricular Fibrillation | 1992 |